Recently, a prospective cohort study demonstrated that reduced HSP90A in blood and cartilage tissue was associated with a higher risk of developing osteoarthritis, suggesting that reduced CMA levels may predict a higher incidence of osteoarthritis.235. Here, HSP90AA1 is linked to osteoarthritis.